FDA Approves Nalmefene, a Longer-Lasting Opioid Reversal Nasal Spray

被引：7

|

作者：

Harris, Emily

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 23期

关键词：

D O I：

10.1001/jama.2023.9608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：2012 / 2012

页数：1

相关论文

共 12 条

[1] FDA approves first OTC naloxone nasal spray for reversal of opioid overdose
Reactions Weekly, 2023, 1952 (1) : 3 - 3
[2] Nalmefene Nasal Spray (Opvee) for Reversal of Opioid Overdose
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1687): : 166 - 167
[3] FDA approves RiVive naloxone nasal spray for opioid overdose
Reactions Weekly, 2023, 1969 (1) : 2 - 2
[4] FDA approves first naloxone nasal spray for opioid overdose
Reactions Weekly, 2015, 1580 (1) : 1 - 1
[5] FDA approves migraine nasal spray
不详
NURSE PRACTITIONER, 2023, 48 (05) : 48 - 48
[6] FDA approves nalmefene auto-injector for opioid overdose
Reactions Weekly, 2024, 2022 (1) : 5 - 5
[7] FDA approves naloxone 8mg nasal spray for opioid overdose
Reactions Weekly, 2021, 1855 (1) : 3 - 3
[8] FDA Approves First Epinephrine Nasal Spray
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2024, 124 (12) : 17 - 17
[9] FDA Approval Summary: Nalmefene Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose
Nallani, Srikanth C.
Li, Zhihua
Florian, Jeffry
Xu, Yun
Sabarinath, Sreedharan
Brescia-Oddo, Tanya
Roca, Rigoberto A.
Uppoor, Ramana S.
Mehta, Mehul U.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (03) : 620 - 626
[10] FDA Approves Easy-to-use Naloxone Nasal Spray
不详
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2016, 30 (01) : 77 - +